|
Home | Medical-Newswire.Com:
|
 (Medical-NewsWire.com, October 26, 2016 ) Publisher's, "Amyloid Protein Blockers-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Amyloid Protein Blockers. The Publisher's Report covers the product profiles in various stages...
Source: EmailWire.com
 (Medical-NewsWire.com, October 26, 2016 ) Publisher's, "Catechol-O-methyltransferase (COMT) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Catechol-O-methyltransferase (COMT) Inhibitors. The Publisher's Report...
Source: EmailWire.com
 (Medical-NewsWire.com, October 26, 2016 ) insights on the pipeline drugs and their development activities around the Beta Secretase inhibitors. The Publisher's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III...
Source: EmailWire.com
 (Medical-NewsWire.com, October 26, 2016 ) Publisher's, "Factor IIa (Thrombin) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Factor IIa (Thrombin) Inhibitors. The Publisher's Report covers the product profiles...
Source: EmailWire.com
 (Medical-NewsWire.com, October 26, 2016 ) Publisher's, "D4 Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the D4 Antagonists. The Publisher's Report covers the product profiles in various stages of development...
Source: EmailWire.com
 (Medical-NewsWire.com, October 26, 2016 ) Publisher's, "Interleukin-13 (IL-13) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Interleukin-13 (IL-13) Inhibitors. The Publisher's Report covers the product profiles...
Source: EmailWire.com
 (Medical-NewsWire.com, October 26, 2016 ) Publisher's, "HIV-2 Protease (HIV-2 PR) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the HIV-2 Protease (HIV-2 PR) Inhibitors. The Publisher's Report covers the product...
Source: EmailWire.com
 (Medical-NewsWire.com, October 26, 2016 ) Publisher's, "Neuropeptide Y Receptor Y5 (NPY5R) Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Neuropeptide Y Receptor Y5 (NPY5R) Antagonists. The Publisher's Report...
Source: EmailWire.com
 (Medical-NewsWire.com, October 26, 2016 ) Publisher's, "mRNA Guanylyltransferase Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the mRNA Guanylyltransferase Inhibitors. The Publisher's Report covers the product...
Source: EmailWire.com
 (Medical-NewsWire.com, October 26, 2016 ) General herpes is a sexually transmitted infection (STI), caused by herpes simplex virus. It causes painful blisters on the genital organs and surrounding areas of both men and women. It also affects mucus membrane present in the body. Prevalence rate of...
Source: EmailWire.com
 (Medical-NewsWire.com, October 26, 2016 ) Publisher's, "SMO (Smoothened) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the SMO (Smoothened) Inhibitors. The Publisher's Report covers the product profiles in various...
Source: EmailWire.com
 (Medical-NewsWire.com, October 26, 2016 ) Publisher's, "Receptor For Advanced Glycation End Product (RAGE) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Receptor For Advanced Glycation End Product (RAGE) Inhibitors....
Source: EmailWire.com
 (Medical-NewsWire.com, October 26, 2016 ) Publisher's, "Fibroblast activation protein (FAP) antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast activation protein (FAP) antagonists. The Publisher's Report...
Source: EmailWire.com
 (Medical-NewsWire.com, October 26, 2016 ) Publisher's, "Thromboxane Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Thromboxane Antagonists. The Publisher's Report covers the product profiles in various stages...
Source: EmailWire.com
 (Medical-NewsWire.com, October 26, 2016 ) Publisher's, "Ubiquitin conjugating enzyme inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Ubiquitin conjugating enzyme inhibitors. The Publisher's Report covers the...
Source: EmailWire.com
|
|
|
|
